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Prenatal Prediction of Pulmonary Hypoplasia: Clinical, Biometric,
and Doppler Velocity Correlates
Jacqueline A. M. Laudy, MD, PhD*; Dick Tibboel, MD, PhD‡; Simon G. F. Robben, MD, PhD§;
Ronald R. de Krijger, MD, PhD; Maria A. J. de Ridder, MSc¶; and Juriy W. Wladimiroff, MD, PhD*
ABSTRACT. Objectives. To determine the value of
pulmonary artery Doppler velocimetry relative to fetal
biometric indices and clinical correlates in the prenatal
prediction of lethal lung hypoplasia (LH) in prolonged
(>1 week) oligohydramnios.
Methods. Forty-two singleton pregnancies with oli-
gohydramnios associated with premature rupture of
membranes ([PROM]; n 31) or bilateral renal pathology
(n  11) were examined using color-coded Doppler ultra-
sound in a cross-sectional study design. Mean gestational
age was 28.0  4.3 weeks (range: 20–36 weeks). Thoracic,
cardiac, and abdominal circumference and the largest
vertical amniotic fluid pocket were measured. Pulsed
Doppler measurements of the arterial pulmonary
branches were made at the level of the cardiac 4-chamber
view. Diagnosis of LH was based on clinical, radiologic,
and pathologic criteria. Clinicians were blinded to the
prenatal measurements.
Results. The prevalence of lethal LH was 43%. In the
PROM subset, combination of onset of PROM at <20
weeks, duration of oligohydramnios at >8 weeks, and
degree of oligohydramnios at <1 cm presented the high-
est clinical prediction rate for lethal LH. For both the total
group and the PROM subset, the highest prediction rate
for lethal LH was presented by thoracic circumference/
abdominal circumference ratio, peak systolic velocity in
the proximal branch, and time-averaged and end-dia-
stolic velocity in the middle branch of the pulmonary
artery. In the PROM subset, the combination of all 3
clinical, biometric, and Doppler parameters revealed the
most favorable combination to predict lethal LH (posi-
tive predictive value: 100%; accuracy: 93%; and sensitiv-
ity: 71%).
Conclusion. Doppler velocimetry may detect changes
in pulmonary artery waveforms in the presence of LH
but fails to be the ultimate test for the prenatal prediction
of lethal LH. The best prediction can be achieved by
combining clinical, biometric, and Doppler parameters.
Pediatrics 2002;109:250–258; human fetus, pulmonary hy-
poplasia, pulmonary circulation, premature rupture of
membranes, oligohydramnios, Doppler velocimetry.
ABBREVIATIONS. PROM, premature rupture of membranes; LH,
lung hypoplasia; PPV, positive predictive value; SD, standard
deviation; PSV, peak systolic velocity; PDV, peak diastolic veloc-
ity; EDV, end-diastolic velocity; TAV time-averaged velocity; PI,
pulsatility index; TC, thoracic circumference; CC, cardiac circum-
ference; AC, abdominal circumference; SDS, standard deviation
score; CI, confidence interval.
Pulmonary hypoplasia is the result of a devel-opmental delay in pulmonary development,which is classically characterized by an abnor-
mal low value of the lung/body weight ratio and
radial alveolar count.1–3 Most commonly, prolonged
oligohydramnios attributable to premature rupture
of membranes (PROM) or renal and urinary tract
malformations may lead to abnormal fetal lung de-
velopment with subsequent severe respiratory dis-
tress immediately after birth and even neonatal
death.1,4,5
An accurate prenatal test for detecting pulmonary
hypoplasia is still highly desirable. Whereas the pre-
diction of nonlethal forms of pulmonary hypoplasia
will not really change obstetric management, this
will be the case for the lethal form. An accurate and
patient-friendly method for early detection and sep-
aration of lethal from nonlethal pulmonary hypopla-
sia should therefore be developed. Ultrasonography
can be considered such a methodology that allows
appropriate obstetric management and parental
counseling in the presence of lethal lung hypoplasia
(LH). For this purpose, a positive predictive value
(PPV) of 100% is needed.
Various methods have been proposed in this re-
spect. Fetal 2-dimensional biometric indices6,7 are
late indicators of pulmonary hypoplasia, with a sen-
sitivity and specificity not satisfactory for clinical
management. Data on the predictive value of the
presence or absence of fetal breathing movements
are contradictory.8,9 Furthermore, the applicability of
3-dimensional ultrasonography, computerized to-
mography, and/or magnetic resonance imaging for
accurate measurement of fetal lung volume in the
prediction of LH still needs to be determined. The
introduction of more sensitive color-coded Doppler
systems has led to the visualization of the human
fetal pulmonary circulation. Information on normal
fetal pulmonary circulation has been obtained in our
center.10,11 As a result, gestation-related changes in
pulmonary blood flow velocity waveforms have
been reported by us.10,11 Only sparse data are avail-
able on the inverse relationship between Po2 and
downstream impedance in the peripheral pulmonary
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arteries, established in growth-restricted human fe-
tuses.12
It has been shown in postmortem studies that pul-
monary hypoplasia is associated with underdevelop-
ment and structural changes of the pulmonary vas-
cular bed. A decrease in the total size of the
pulmonary vascular bed, a decrease in the number of
vessels per unit of lung tissue, and an increase of
pulmonary arterial smooth muscle thickness have
been described.4,13,14 We hypothesized that these
changes may lead to increased pulmonary vascular
resistance and decreased pulmonary arterial compli-
ance. These alterations may effect pulmonary blood
flow and consequently may induce changes in both
systolic and diastolic components of the pulmonary
artery flow velocity waveform as suggested previ-
ously.15 On the basis of this hypothesis, we ad-
dressed the question of whether 1) Doppler flow
velocity waveforms from the fetal arterial pulmonary
branches in the presence of prolonged oligohydram-
nios are predictive of lethal LH and, if so, 2) whether
the predictive value of these Doppler recordings is
superior to that of fetal biometric indices.
METHODS
Patients and Study Design
A total of 42 women with a singleton pregnancy and prolonged
oligohydramnios were evaluated on referral in a random manner.
Each woman consented to participating in the study, which was
conducted according to a cross-sectional design. Prolonged oligo-
hydramnios was considered the common denominator for the
inclusion of patients is this study. Oligohydramnios was either the
result of PROM before 30 weeks of gestation and lasting 1 week
(n 31) or attributable to the presence of bilateral renal pathology
(n 11). The latter subset consisted of bilateral renal agenesis (n
5), bilateral cystic/dysplastic kidneys (n  4), and obstructive
uropathy (n  2), suspected prenatally by ultrasonography and
confirmed postnatally by postmortem examination. It is realized
that the underlying mechanism of oligohydramnios in PROM is
different from that in fetal renal malformations.16 The degree of
oligohydramnios was defined as severe, moderate, or mild when
the largest vertical amniotic fluid pocket was measured below 1
cm, between 1 and 2 cm, and between 2 and 3 cm, respectively.5
Other causes of LH, such as diaphragmatic hernia and neurologic
and skeletal disorders, were excluded from the study.
The study protocol was approved by the Hospital Ethics Com-
mittee and conformed with the principles outlined in the Decla-
ration of Helsinki. Pregnancy duration varied between 20 and 36
weeks (mean: 28 weeks; standard deviation [SD]: 4.3) and was
determined from the last menstrual period and confirmed or
adjusted by ultrasonic measurement of the fetal crown-rump
length (8–12 weeks) or fetal biparietal diameter (12–20 weeks).
There was no fetal growth restriction, maternal smoking, drug
ingestion, or maternal disease. Abnormal fetal pulmonary vascu-
lature was therefore considered to be associated with pulmonary
hypoplasia. No other pregnancy pathology was established. De-
mographic data are presented in Table 1. Pregnancy duration was
beyond 34 weeks in 5 of 31 PROM cases. In the PROM subset,
cesarean section was always performed because of fetal distress.
In this particular subset, 27 of 31 patients received corticosteroids.
Of the remaining 4 patients, we could not traced whether this
medication was administered. Two of these patients delivered a
fetus with lethal LH, and 2 delivered a fetus without LH.
The mean onset of PROM was 23 weeks (SD: 3.9), and the mean
duration of PROM was 8 weeks (SD: 4.4). Within the PROM
subset, 11 cases (35%) had a vertical amniotic fluid pocket of 1
cm, 13 cases (42%) of 1 cm and 2 cm, and 7 cases (23%) of 2
cm and 3 cm. All cases with renal pathology displayed amniotic
fluid pockets 1 cm. The mean time interval between the sono-
graphic measurements and delivery was 6 days (PROM subset)
and 4 days (renal subset), respectively.
Recording Technique
The real-time ultrasound and Doppler studies were performed
using a Toshiba SSH 140 with combined transabdominal real-time,
color and pulsed Doppler imaging facilities (Toshiba Corp, Med-
ical Systems Division, Tokyo, Japan). The carrier frequency was 5
MHz (real time) and 3.75 MHz (Doppler). The spatial peak tem-
poral average power output was 100 mW/cm2 in both imaging
and Doppler modes according to manufacturer’s specifications.
All recordings were performed with the woman in the semire-
cumbent position and during fetal apnea.
Thoracic, cardiac, and abdominal circumference and the largest
vertical amniotic fluid pocket were measured as described else-
where.17,18 This was followed by the pulsed Doppler measure-
ments of the arterial pulmonary branches from a transverse cross-
section of the fetal chest at the level of the cardiac 4-chamber view
after visualization with color Doppler. Depending on fetal posi-
tion, the right or left lung was examined. Doppler waveforms
(sample volume: 0.1–0.3 cm) were first obtained from the most
proximal branch of the pulmonary artery, then in the middle lung
region at equal distance from the outer border of the heart and the
inner thoracic wall and subsequently in the distal lung region as
close as possible to the fetal inner thoracic wall (Fig 1).10,11 The
interrogation angle was always kept below 20 degrees. The high-
pass filter was set at 100 Hz, and when no end-diastolic or early
diastolic reverse flow velocities were present, the filter was set at
70 Hz. All flow velocity waveforms were recorded on hard copies.
Each patient was studied by 1 and the same examiner (J.A.M.L.),
who also performed the waveform analysis, using a microcom-
puter (Commodore 386 CX) linked to a graphics tablet. At least 3
consecutive flow velocity waveforms with the highest velocity and
of similar appearance were used to calculate the different param-
eters in each vessel. The flow velocity waveform pattern at all 3
levels has been described previously.10,11 Adequate accuracy and
precision of the recording technique was achieved in a separate
control group.11 Clinicians were blinded to the Doppler results.
From the proximal, middle, and distal arterial pulmonary
branches, the following Doppler flow velocity parameters were
determined from the same lung: 1) peak systolic velocity (PSV,
cm/s), peak diastolic velocity (PDV, cm/s), end diastolic velocity
TABLE 1. Demographics of the Subset of PROM and the Subset of Bilateral Renal Pathology
PROM
(n  31)
Renal Pathology
(n  11)
Maternal age (y; mean [SD]) 28.8 (4.6) 29.8 (3.6)
Gravida (median [range]) 3 [1–6] 2 [1–6]
Para (median [range]) 1 [0–4] 1 [0–4]
Interval US–birth (wk; median [range]) 0.86 [0.14–6.71] 0.57 [0.14–7.00]
Gestation at birth (wk; mean [SD]) 30.48 (2.95) 27.79 (7.13)
Birth weight (g); median [range]) 1305 [780–2750] 730 [303–2765]
Mode of delivery
Spontaneous 25 (81%) 4 (36%)
Cesarean section 6 (19%) 0
Pregnancy termination 0 7 (64%)
Gender (male/female) 18/13 9/2
US indicates ultrasonographic examination.
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(EDV, cm/s), and time-averaged velocity (TAV, cm/s); and 2) the
pulsatility index (PI  [PSV  EDV]/TAV).19
Postnatal Diagnosis of LH
After birth, LH was diagnosed according to clinical and radio-
logic criteria and eventually pathologic data. Pathologic data were
based on lung/body weight ratios and radial alveolar counts
according to Askenazi and Perlman.2 When the radial alveolar
counts could not be determined, which was particularly the case
in early pregnancy (20–22 weeks), pulmonary hypoplasia was
defined as wet lung/body weight ratio of0.015 before 28 weeks’
gestation, or 0.012 at 28 weeks or later, including the develop-
mental stage.3 The clinical criteria were defined as immediate
onset of severe respiratory insufficiency after birth, small lung
capacity, and requirement of high ventilatory pressures in the
absence of obstruction or atelectasis.5,20 Radiologic criteria consti-
tuted small lung fields with diaphragmatic domes elevated up to
the seventh rib, downward-sloping ribs, a bell-shaped chest,
and/or pneumothorax/pneumomediastinum.21,22 The radiologist
(S.G.F.R.) who scored the radiographs of the neonatal chest was
blinded to the sonographic measurements and neonatal outcome.
Lethal LH was defined as death from LH based on criteria
described above. Fetuses with autopsy-proven LH after early
pregnancy termination were included. Neonates with nonlethal
LH developed respiratory insufficiency compatible with clinical
and radiologic signs of pulmonary hypoplasia but survived. Ab-
sent LH was represented by 1) neonates who did not show any
clinical and/or radiologic sign of pulmonary hypoplasia and 2)
fetuses in which no pulmonary hypoplasia could be diagnosed on
postmortem examination after early pregnancy termination.
From a clinical standpoint, an accurate prenatal prediction of a
lethal form of pulmonary hypoplasia is important to both obstetric
management and parental counseling. It was decided, therefore,
to separate out lethal LH from nonlethal and absent LH in the
present study.
Data Analysis
Clinical Parameters (PROM Subset Only)
The onset of PROM and the duration and degree of oligohy-
dramnios served as clinical parameters for the prediction of lethal
LH. The selection of these parameters and associated cutoff levels
Fig 1. Cross-section of the fetal chest
at the level of the cardiac 4-chamber
view with color Doppler switched on
to visualize the pulmonary circulation.
Proximal, middle, distal  proximal,
middle and distal Doppler sample site
in the arterial pulmonary branch.
TABLE 2. Efficacy of the Clinical Parameters in the Prenatal Prediction of Lethal LH in the Subset of PROM
Clinical Parameters Cutoff
Levels
Subset of PROM (n  31)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Onset of PROM 20 wk1 78 77 58 89 77
24 wk 100 45 43 100 61
26 wk 100 32 38 100 52
Duration of oligohydramnios 8 wk2 89 59 47 93 68
6 wk 100 50 45 100 65
4 wk 100 41 41 100 58
Degree of oligohydramnios 1 cm3 78 82 64 90 81
2 cm 100 32 38 100 52
Combination of parameters with
the most accurate cutoff level (123)
67 95 86 88 87
NPV indicates negative predictive value.
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(Table 2) was based on their predictive value of pulmonary hyp-
oplasia suggested in previous reports.5,23,24 Differences in clinical
parameters between lethal LH and combined nonlethal and absent
LH were tested (independent sample t test). For the onset of
PROM, we examined the levels of 26 weeks, 24 weeks, and
20 weeks of gestation; for the duration of oligohydramnios, the
levels of 4 weeks, 6 weeks, and 8 weeks; and for the degree
of oligohydramnios, a largest vertical amniotic fluid pocket of 2
cm and1 cm. Furthermore, sensitivity, specificity, PPV, negative
predictive value, and overall accuracy for lethal LH were calcu-
lated at the different cutoff levels for each of these clinical param-
eters separately and in combination. Accuracy was defined as the
sum of true “positives” and true “negatives” divided by the total
population studied. Data were considered abnormal when situ-
ated below a particular cutoff level for onset of PROM or degree
of oligohydramnios and above a particular cutoff level for dura-
tion of oligohydramnios.
Biometric and Doppler Parameters
Data on thoracic circumference (TC) and ratios of cardiac/
thoracic circumference (CC/TC) and thoracic/abdominal circum-
ference (TC/AC) as well as pulmonary Doppler flow velocities
were plotted in nomograms constructed from an previous patient
cohort of 111 uncomplicated singleton pregnancies.10,11 All pa-
rameters were subsequently converted into the standard deviation
scores (SDS) to be independent of gestational age. We tested
whether the SDS of both the lethal LH subset and combined
nonlethal and absent LH subset were statistically different from
the SDS of the mean of the normal controls ( 0) using the
1-sample t test. For the latter subset, we also tested whether this
result was influenced by the addition of the 3 cases of nonlethal
LH to the subset of absent LH. The level of statistical significance
was set at P  .05. Furthermore, sensitivity, specificity, predictive
values, and overall accuracy of the separate and combined bio-
metric and Doppler parameters were calculated for the total study
group to evaluate the efficacy of prenatal prediction of lethal
pulmonary hypoplasia. A similar procedure was conducted
within the PROM subset, including combination of onset of PROM
and duration and degree of oligohydramnios. Exact 95% confi-
dence intervals (CI) were computed with the package StatXact 4
(Cytel Software Corporation, Cambridge, UK) for all tested com-
binations. Measurements below the 5th centile were considered
abnormal for TC and TC/AC and the velocity parameters TAV,
PSV, PDV, and EDV, and measurements above the 95th centile
were considered abnormal for CC/TC and PI.
RESULTS
Pregnancy Outcome
The prevalence of lethal LH in the total study
group was 43% (18 of 42), 9 of which were in the
PROM subset (9 [29%] of 31) and 9 of which were in
the renal subset (9 [82%] of 11). Nonlethal LH was
established in 3 cases associated with PROM, and
absent LH existed in the remaining 21 cases, 19 of
which were related to PROM.
In the renal subset, the mortality rate was 100% (11
of 11); 2 cases (bilateral renal agenesis and bilateral
cystic kidneys) displayed normal lung/body weight
ratios after termination of pregnancy at 21 weeks of
gestation. In the PROM subset, the overall mortality
rate was 39% (12 of 31). Of the 9 fetuses with lethal
LH, 78% (n 7) died within 24 hours after birth, 70%
(5 of 7) of which died in the first hour. Despite
vigorous artificial ventilation with 100% inspiratory
oxygen and frequencies ranging from 30 to 100 per
minute and peak inspiratory pressures reaching 40
cm H2O in isolated cases, adequate oxygenation was
never reached in severely affected neonates. In ab-
sent LH (n  19), 3 neonates died from sepsis (n  2)
or severe asphyxia (n  1). The remaining 16 neo-
nates survived, although 81% of them (13 of 16)
displayed mild to severe respiratory complications.
All 3 neonates with nonlethal LH in this PROM
subset developed respiratory distress syndrome,
complicated by persistent pulmonary hypertension
and, later, bronchopulmonary dysplasia.
In the subset of PROM, an intrauterine infection
was suspected in 17 cases (55%). In 11 of these
cases (65%), there were histopathologic signs of a
(chorio)amnionitis. Two of these 11 cases had clinical
signs of an infection confirmed by culture, which
caused their death. There were no other cases of a
clinical infection in the group of PROM. In 6 of the 9
cases of lethal LH, an intrauterine infection was sus-
pected and 5 of them had a chorioamnionitis. How-
ever, none of these neonates developed signs of in-
fection. The 3 cases of nonlethal LH cases had no
neonatal signs of infection confirmed by negative
cultures.
Clinical Parameters (PROM Subset Only)
The median time interval between the onset of
PROM and sonographic examination was 7 weeks
(range: 1–20 weeks). The mean onset of PROM was
significantly earlier (19.7 weeks [SD: 2.1]) vs 23.9
weeks [SD 3.9]; P  .005), the mean duration of
oligohydramnios was significantly longer (10.0
weeks [SD: 1.2] vs 6.8 weeks [SD 4.9]; P  .008), and
the mean degree of oligohydramnios was signifi-
cantly more pronounced (0.9 cm [SD: 0.5] vs 1.7 cm
[SD: 0.8]; P  .01) in the subset of lethal LH com-
pared with combined nonlethal and absent LH. The
highest prediction rate for lethal LH was presented
by 1) onset of PROM 20 weeks, 2) duration of
oligohydramnios 8 weeks, and 3) degree of oligo-
hydramnios of 1 cm. The best prediction rate (PPV:
86% [95% CI: 42%–100%]; accuracy: 87% [95% CI:
70%–96%]) was reached when combining 1 through
3 (Table 2).
Biometric Parameters
TC and CC/TC and TC/AC ratios could be calcu-
lated in 98% of all patients and in 97% of the
PROM subset. Figure 2 demonstrates the TC and
CC/TC and TC/AC ratios for the total study group
plotted in the normal reference charts. The SDS of all
3 biometric parameters were statistically signifi-
cantly different from the SDS of the mean of normal
control subjects for both the subset of lethal LH and
the subset of combined nonlethal and absent LH. For
TC and CC/TC, this was independent of the addition
of the 3 cases of nonlethal LH to the subset of absent
LH. TC/AC ratio displayed the best PPV and overall
accuracy in the prenatal prediction of lethal LH for
both the total group and the subset of PROM (Tables
3 and 4).
Doppler Velocity Parameters
Technically acceptable proximal, middle, and dis-
tal arterial pulmonary branch flow velocity wave-
forms were obtained in 88%, 81%, and 55%, respec-
tively, for the total study group and in 94%, 84%, and
68%, respectively, for the PROM subset. A significant
(P  .03) difference existed between lethal LH (6
[33%] of 18) and combined nonlethal and absent LH
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(17 [71%] of 24) concerning distal waveforms, which
were therefore omitted from further analysis.
For the total study group, the SDS of TAV, PSV,
PDV, and EDV from both the proximal and middle
arterial waveforms were statistically significantly
different from the SDS of the mean of normal control
subjects for both lethal LH and combined nonlethal
and absent LH. This was independent of the addition
of the 3 cases of nonlethal LH to the subset of absent
LH. For the PI, this applied only to the proximal
arterial waveforms.
For both the total group and the subset of PROM,
the highest PPV and overall accuracy in the prenatal
prediction of lethal LH were achieved for the PSV of
the proximal arterial waveforms and for the TAV
and EDV of the middle arterial waveforms. The
(nearly) lowest PPV and overall accuracy were pre-
sented by the PI (Tables 3 and 4; Figs 3 and 4).
Combination of Clinical, Biometric, and Doppler
Parameters
In the total study group, when combining TC/AC
and proximal arterial pulmonary PSV, the success
rate of obtaining this combination was 86% (36 of 42).
Lethal LH existed in 3 of the 6 unsuccessful cases,
leaving 15 of 18 cases of lethal LH for analysis of the
combined data. Lethal LH was predicted when both
TC/AC and PSV were situated below the 5th centile
of the normal reference charts, resulting in a PPV of
100% (95% CI: 54%–100%) and an overall accuracy of
75% (95% CI: 58%–88%), with a drop in sensitivity to
40% (6 of 15; 95% CI: 16%–68%; Table 3). Thus, lethal
LH was detected in 6 of 18 cases.
In the subset of PROM, further improvement in
predictive value was sought in 1) combined clinical
parameters and TC/AC; 2) combined clinical param-
Fig 2. Individual values from the total study group compared with reference ranges (mean, 5th and 95th centiles) for (A) thoracic
circumference (TC, mm), (B) ratio of cardiac and thoracic circumference (CC/TC) and (C) ratio of thoracic and abdominal circumference
(TC/AC) relative to gestational age. The solid circles represent group 1, ie, fetuses with lethal LH and the open blocks represent group
2, ie, fetuses with nonlethal and absent LH.
TABLE 3. Efficacy of the Biometric and Doppler Parameters in the Prenatal Prediction of lethal LH in the Total Study Group
Total Study Group (n  42)
Success
Rate
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Prevalence LLH 43% (18/42)
Biometric parameters
TC 41/42 (98%) 94 38 52 90 61
CC/TC 41/42 (98%) 76 50 52 75 61
TC/AC* 40/42 (95%) 69 71 61 77 70
Doppler parameters
Proximal pulmonary branch 37/42 (88%)
TAV 69 76 69 76 73
PSV* 63 90 83 76 78
PDV 44 90 78 68 70
EDV 50 86 73 69 70
PI 56 76 64 70 68
Middle pulmonary branch 34/42 (81%)
TAV 71 80 71 80 76
PSV 43 80 60 67 65
PDV 43 70 50 64 59
EDV 57 90 80 75 76
PI 29 75 44 60 56
Combination of parameters
Biometry  Doppler 36/42 (86%) 40 100 100 70 75
NPV indicates negative predictive value.
* Variables used for the biometric and Doppler combination.
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eters and proximal PSV; 3) combined TC/AC and
proximal PSV; and 4) combined clinical parameters,
TC/AC, and proximal PSV (Table 4). In the first 3
combinations (1–3), lethal LH was considered
present when both variables were abnormal. The
success rate in obtaining the first combination was
97% (30 of 31), with 1 unsuccessful case of lethal LH,
resulting in 8 of 9 cases of lethal LH for further
analysis. This combination showed a PPV of 100%
(95% CI: 29%–100%), an overall accuracy of 83%
(95% CI: 65%–94%), and a sensitivity of only 38% (3
of 8; 95% CI: 9%–76%). The success rate of the second
combination was 94% (29 of 31). Lethal LH existed in
1 of the 2 unsuccessful cases, leaving 8 of 9 cases of
lethal LH for analysis of the combined data. The PPV
of this combination also reached the level of 100%
(95% CI: 40%–100%) with an accuracy of 86% (95%
CI: 68%–96%) and a sensitivity of 50% (4 of 8; 95% CI:
16%–84%). The third combination was successful in
90% (28 of 31), with 2 cases of lethal LH of the 3
unsuccessful cases, resulting in 7 of 9 cases of lethal
LH for analysis. The PPV improved to 100% (95% CI:
16%–100%) with an accuracy of 82% (95% CI: 6%–
94%) and a sensitivity of 29% (2 of 7; 95% CI: 4%–
71%). With these 3 combined tests, lethal LH could
be detected in 3, 4, and 2 of 9 cases, respectively. The
Fig 3. Individual values from the total study group compared with reference ranges (mean, 5th and 95th centiles) for (A) PSV (cm/s) of
the proximal arterial pulmonary branch, (B) time-averaged velocity (TAV, cm/s) and (C) end-diastolic velocity (EDV, cm/s) of the middle
arterial pulmonary branch relative to gestational age. The solid circles represent group 1, ie, fetuses with lethal LH and the open blocks
represent group 2, ie, fetuses with nonlethal and absent LH.
TABLE 4. Efficacy of the Biometric and Doppler Parameters Including the Combination With the Clinical Parameters in the Prenatal
Prediction of lethal LH in the Subset of PROM
Subset of PROM (n  31)
Success
Rate
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Prevalence LLH 29% (9/31)
Biometric parameters
TC 100% 100 36 39 100 55
CC/TC 100% 78 50 39 85 58
TC/AC* 97% (30/31) 63 73 45 84 70
Doppler parameters
Proximal pulmonary branch 94% (29/31)
TAV 63 76 50 84 72
PSV* 63 90 71 86 83
PDV 25 90 50 76 72
EDV 38 86 50 71 72
PI 38 76 38 76 66
Middle pulmonary branch 84% (26/31)
TAV 71 84 63 89 81
PSV 43 84 50 80 73
PDV 14 68 14 68 54
EDV 57 95 80 86 85
PI 29 79 33 75 65
Combination of parameters
Clinical (Table 2) 100% 67 95 86 88 87
Clinical Biometry 97% (30/31) 38 100 100 81 83
Clinical Doppler 94% (29/31) 50 100 100 84 86
Biometry  Doppler 90% (28/31) 29 100 100 81 82
Clinical  Biometry  Doppler 94% (29/31) 71 100 100 92 93
LLH indicates lethal lung hypoplasia; NPV, negative predictive value.
*, Variables used for the biometric and Doppler combination; clinical, the combination of the 3 clinical parameters with the most accurate
cutoff points in the prediction of lethal lung hypoplasia, i.e. onset of PROM 20 weeks, duration of oligohydramnios 8 weeks, degree
of oligohydramnios of 1 cm.
ARTICLES 255
 at Erasmus Rotterdam on November 20, 2006 www.pediatrics.orgDownloaded from 
success rate in obtaining the last combination (4) was
94% (29 of 31). Lethal LH existed in both unsuccess-
ful cases, leaving 7 of 9 cases of lethal LH for analysis
of the combined data. Lethal LH was predicted when
at least 2 of the 3 variables were abnormal. PPV,
overall accuracy, and sensitivity demonstrated an
increase up to 100% (95% CI: 48%–100%), 93% (95%
CI: 77%–99%), and 71% (5 of 7; 95% CI: 29%–96%),
respectively (Table 4). Lethal LH was detected in 5 of
9 cases.
DISCUSSION
The present study describes the role of clinical,
biometric, and Doppler parameters, separate or in
combination, in the prenatal prediction of lethal LH
in pregnancies associated with prolonged oligohy-
dramnios of renal or nonrenal (PROM) origin.
Surrounding amniotic fluid is important for opti-
mal fetal lung growth. Although the association be-
tween oligohydramnios and pulmonary hypoplasia
is well documented, the underlying mechanisms for
this phenomenon have not been fully elucidated.
Several explanations have been put forward: 1) de-
creased space for lung growth as a result of pressure
of the uterine wall on the fetal chest and abdomen;
2) restriction of fetal breathing movements by pro-
longed thoracic compression; and 3) increased efflux
of lung liquid from the intrapulmonary space to the
amniotic space, resulting in a decrease of intrapul-
monary pressure.25,26 Oligohydramnios may result
from a different cause, such as lack of fetal urinary
production associated with renal abnormalities, se-
vere fetal growth restriction, and ruptured mem-
branes.
In case of pulmonary hypoplasia associated with
oligohydramnios, the severity of this abnormal con-
dition depends on the degree and duration of oligo-
hydramnios and the stage of lung development.5,23
The present study confirms the existence of a signif-
icant relation among onset of PROM, duration and
degree of oligohydramnios, and the development of
lethal LH. The PPV of a prenatal test for detecting
lethal LH should be 100% to be used in obstetric
management. Onset of PROM and duration and de-
gree of oligohydramnios as separate variables dis-
played the highest prenatal prediction of lethal LH at
the cutoff levels of20 weeks,8 weeks, and1 cm,
respectively. However, neither the corresponding
predictive values and accuracy for each of these clin-
ical parameters separately nor their combination
reached an acceptable level for clinical application.
Because only 2 of 31 neonates in the subset of
PROM died from sepsis, pre- and/or postnatally
confirmed infection was considered not to be a con-
founder of the predictive variables in the present
study.
Prediction of lethal pulmonary hypoplasia has
been attempted from fetal TC and sagittal lung
length or transversal lung diameter measurements,
as well as from CC/TC and TC/AC ratios.6,7,27 Most
biometric studies represent heterogeneous and rela-
tively small patient cohorts and use different defini-
tions of TC and LH. Moreover, none of these biomet-
ric tests was reliable enough to be applied in clinical
management. Also, in the present study, TC, CC/TC,
and TC/AC failed to provide an acceptable prenatal
prediction of lethal LH in either the total study group
or the subset of PROM. In the latter, the clinical
parameters reached an even better prediction rate
than the biometric parameters.
Remarkable is the finding that mean SDS of the
biometric parameters from not only the lethal LH
subset but also the combined nonlethal and absent
LH subset was significantly different from the SDS of
the mean of the normal control subjects. For the TC
and the CC/TC, this was also the case for absent LH
alone. We propose that mechanical compression as-
sociated with marked oligohydramnios and/or pos-
sible interference with fetal breathing movements
may play a role in this phenomenon, independent of
the occurrence of lethal LH.
Because prenatal fetal biometry has failed to pro-
vide an accurate prediction of pulmonary hypopla-
sia, other methods had to be explored. A prolonged
and pronounced oligohydramnios, particularly dur-
ing the canalicular phase of lung development (from
Fig 4. Individual values from the total study group compared with reference ranges (mean, 5th and 95th centiles) for (A) PI of the
proximal arterial pulmonary branch and (B) PI of the middle arterial pulmonary branch relative to gestational age. The solid circles
represent group 1, ie, fetuses with lethal LH and the open blocks represent group 2, ie, fetuses with nonlethal and absent LH.
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18 to 26 to 28 weeks of gestation), may cause a delay
or even an arrest in pulmonary vascular develop-
ment, resulting in reduced lung volume and raised
pulmonary vascular resistance.4,13 Consequently, the
present study focused on the possible contribution of
Doppler velocimetry of the arterial pulmonary circu-
lation for the improvement of prenatal prediction of
LH. In the total study group, the success rate of
obtaining technically acceptable proximal and mid-
dle arterial pulmonary branch flow velocity wave-
forms was similar to that reported previously in
uncomplicated pregnancies.10,11 Regarding the sub-
set of lethal LH alone, the percentage of technically
acceptable distal waveforms was significantly less
(33%) compared with the subset of combined nonle-
thal and absent LH (71%). This suggests that failure
to record distal arterial flow velocity waveforms may
be indicative of lethal LH. So far, comparison with
other studies is not possible because of differences in
definition of Doppler sample site for distal pulmo-
nary arteries.28,29
Similar to the fetal biometric parameters, nearly all
mean SDS of the proximal and middle arterial pul-
monary flow velocity waveforms from the subset of
combined nonlethal and absent LH were signifi-
cantly different from the SDS of the mean of normal
control subjects, independent of the addition of the 3
cases of nonlethal LH to the subset of absent LH. In
the normally developing fetus, fluid leaves the pul-
monary vasculature, passes through the interstitium
of the lungs entering the potential air spaces, and
flows out of the trachea. It has been postulated that
oligohydramnios increases efflux of lung liquid from
the intrapulmonary space into the amniotic space,
resulting in a decrease of intrapulmonary pres-
sure.25,26 We propose that changes in lung liquid
dynamics, even without dramatic influences on lung
growth resulting in LH, may affect pulmonary blood
flow and consequently pulmonary blood flow veloc-
ity waveforms.
The most reliable Doppler velocity parameters in
the detection of lethal LH were PSV in the proximal
arterial pulmonary velocity waveform and TAV and
EDV in the middle arterial pulmonary velocity
waveform. The majority of the Doppler velocity pa-
rameters from both proximal and middle arterial
pulmonary branches showed even higher PPV and
overall accuracy than the biometric parameters. Nev-
ertheless, Doppler velocimetry of the arterial pulmo-
nary circulation as a single test also failed to be
reliable enough for clinical application. In the subset
of PROM, the 3 combined clinical parameters dis-
played an even higher PPV and accuracy than Dopp-
ler velocimetry.
The lowest PPV and overall accuracy for both the
proximal and middle arterial pulmonary branches
were presented by the PI in the total study group.
The PI is known as a reliable Doppler parameter for
the detection of changes in fetoplacental resistance.
Contradictory views have been reported regarding
the clinical significance of the PI in the prediction of
lethal LH.28–31 These reports present data from very
small heterogeneous patient series and do not in-
clude cases of PROM, which is considered one of the
most common causes of pulmonary hypoplasia.
Because we demonstrated that Doppler velocim-
etry of the arterial pulmonary circulation also fails to
be the single and ultimate prenatal test in the pre-
diction of lethal LH, we addressed the question of
whether combining clinical, biometric, and pulmo-
nary Doppler parameters could improve the predic-
tive value of lethal LH. In the total study group, first
the most accurate biometric parameter, ie, TC/AC,
and the most accurate Doppler parameter, ie, the
proximal arterial pulmonary PSV, were combined.
The PPV improved to 100%. However, this result
could be achieved in only 6 of 18 cases of lethal LH,
which would limit its clinical applicability. When a
similar exercise was conducted in the subset of
PROM, all 3 combinations of 1) combined clinical
parameters and TC/AC, 2) combined clinical param-
eters and proximal PSV, and 3) TC/AC and proximal
PSV reached a PPV of 100%. Also here, a correct
prediction could be made in only 2 to 4 of 9 cases of
lethal LH.
Combination of all 3 clinical, biometric, and Dopp-
ler parameters demonstrated not only a PPV of 100%
but also a considerable improvement in overall ac-
curacy (93%) and sensitivity (71%). Here, a correct
prenatal diagnosis of lethal LH was made in 5 of 9
cases of lethal LH, constituting the most favorable
combination in the subset of PROM.
It is possible that the performance of the predictive
equations defined in the present cohort will not be as
accurate as initially projected when evaluated pro-
spectively in a new group of subjects that possess
clinical characteristics not encountered in the current
group. It is realized that, particularly before 24 weeks
of gestation, a highly predictive test for lethal LH
would be desirable to allow couples to arrive at a
well-balanced decision as to whether to opt for preg-
nancy termination. In the present study, the mean
onset of PROM followed by lethal LH was 19.7
weeks.
It can be concluded that Doppler velocimetry may
detect changes in blood velocity waveforms from the
proximal and middle arterial branches of the fetal
pulmonary circulation in the presence of pulmonary
hypoplasia. The best prediction was achieved in the
subset of PROM, when a combination of clinical,
biometric, and Doppler parameters were applied.
The clinical significance of this combined test, how-
ever, seems to be limited as a result of the restrictions
in obtaining the necessary components of this test
and the low sensitivity of the combination.
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